Five-compartment model of insulin kinetics and its use to investigate action of chloroquine in NIDDM.

We have constructed a five-compartment model of insulin kinetics. The model structure was chosen to reflect insulin distribution in systemic plasma, hepatic plasma, and interstitial fluid and insulin binding to the liver and peripheral receptors, and it included receptor-mediated and non-receptor-mediated insulin degradation. Model parameters were estimated from plasma insulin concentrations measured during hyperinsulinemic euglycemic clamp studies. In the fasting condition, the model-derived mean residence time of endogenously secreted insulin was 71 min, of which 62 min were spent bound to the liver receptor, 6 min bound to the peripheral receptor, 2 min circulating in hepatic or systemic plasma, and 1 min in the interstitial fluid. More than 80% of total insulin was bound to the liver receptor, indicating that the liver is by far the largest insulin reservoir. The model was employed to assess the effect of chloroquine on insulin kinetics in patients with non-insulin-dependent diabetes mellitus (NIDDM). Chloroquine significantly altered parameter vector. However, the mean residence times of insulin in the system and in the periphery were not affected, indicating that the beneficial effect of chloroquine in patients with NIDDM under conditions of euglycemia could not be attributed to changes in insulin kinetics.

[1]  R. Bergman,et al.  Insulin transport across capillaries is rate limiting for insulin action in dogs. , 1989, The Journal of clinical investigation.

[2]  P. Cuatrecasas Properties of the insulin receptor isolated from liver and fat cell membranes. , 1972, The Journal of biological chemistry.

[3]  S. Gammeltoft Insulin receptors: binding kinetics and structure-function relationship of insulin. , 1984, Physiological reviews.

[4]  Charles DeLisi,et al.  Mean residence time—theoretical development, experimental determination, and practical use in tracer analysis☆ , 1984 .

[5]  P. Sönksen,et al.  A comparative study on the metabolism of human insulin and porcine proinsulin in man. , 1973, Clinical science and molecular medicine.

[6]  T. Peters,et al.  Effect of chloroquine on insulin and glucose homoeostasis in normal subjects and patients with non-insulin-dependent diabetes mellitus. , 1987 .

[7]  D. Marquardt An Algorithm for Least-Squares Estimation of Nonlinear Parameters , 1963 .

[8]  K. M. Erickson,et al.  Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior. , 1980, The Journal of clinical endocrinology and metabolism.

[9]  P. Cuatrecasas Properties of the insulin receptor of isolated fat cell membranes. , 1971, The Journal of biological chemistry.

[10]  C. Kahn,et al.  Quantitative aspects of the insulin-receptor interaction in liver plasma membranes. , 1974, The Journal of biological chemistry.

[11]  J. Olefsky,et al.  The trafficking and processing of insulin and insulin receptors in cultured rat hepatocytes. , 1987, Endocrinology.

[12]  C Cobelli,et al.  The kinetics of insulin in man. II. Role of the liver. , 1987, Diabetes/metabolism reviews.

[13]  A. Ullrich,et al.  Endocytotic uptake, processing, and retroendocytosis of human biosynthetic proinsulin by rat fibroblasts transfected with the human insulin receptor gene. , 1988, Journal of Clinical Investigation.

[14]  A Silvers,et al.  Derivation of a three compartment model describing disappearance of plasma insulin-131-I in man. , 1969, The Journal of clinical investigation.

[15]  M Berman,et al.  A model of the kinetics of insulin in man. , 1974, The Journal of clinical investigation.

[16]  W. Duckworth Insulin degradation: mechanisms, products, and significance. , 1988, Endocrine reviews.

[17]  D. Steiner,et al.  Secretion of Proinsulin C-Peptide by Pancreatic β Cells and its Circulation in Blood , 1969, Nature.

[18]  S. Marshall Kinetics of insulin receptor internalization and recycling in adipocytes. Shunting of receptors to a degradative pathway by inhibitors of recycling. , 1985, The Journal of biological chemistry.

[19]  M. Davidson,et al.  Insulin binding and action in isolated rat hepatocytes: evidence for spare receptors. , 1981, Metabolism: clinical and experimental.

[20]  D. Giugliano,et al.  Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug? , 1990, Annals of internal medicine.

[21]  M Berman,et al.  Insulin control of glucose metabolism in man: a new kinetic analysis. , 1975, The Journal of clinical investigation.

[22]  Bruce H. Frank,et al.  Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. , 1986, The Journal of clinical investigation.

[23]  E. Rasio The Capillary Barrier to Circulating Insulin , 1982, Diabetes Care.

[24]  B. Feldt-Rasmussen,et al.  Kinetic models for plasma disappearance of insulin in normal subjects. , 2009, Acta pharmacologica et toxicologica.

[25]  R. Eaton,et al.  Hepatic removal of insulin in normal man: dose response to endogenous insulin secretion. , 1983, The Journal of clinical endocrinology and metabolism.

[26]  H. Pollard,et al.  The cell population of human liver. , 1961, The Journal of laboratory and clinical medicine.

[27]  M L Standaert,et al.  Equilibrium model for insulin-induced receptor down-regulation. Regulation of insulin receptors in differentiated BC3H-1 myocytes. , 1984, The Journal of biological chemistry.

[28]  K. Polonsky,et al.  Differences in the hepatic and renal extraction of insulin and glucagon in the dog: evidence for saturability of insulin metabolism. , 1983, Acta endocrinologica.

[29]  C V Greenway,et al.  Hepatic vascular bed. , 1971, Physiological reviews.